Five-Year Outcomes for Refractory B-Cell Lymphomas with CAR T-Cell Therapy
- PMID: 33596362
- DOI: 10.1056/NEJMc2030164
Five-Year Outcomes for Refractory B-Cell Lymphomas with CAR T-Cell Therapy
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources